Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancer

10 Apr 20264 min read0 viewsJournal Feed

GIST

British Journal of Cancer, Published online: 10 April 2026; doi:10.1038/s41416-026-03432-y Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancer

Clinical Editorial

Summary

British Journal of Cancer published a clinical update in Oncology on 10 Apr 2026.

The item focuses on Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancer.

Review the original article for the full source wording and details.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

Autonomous pathology research using agentic AI shows potential in oncology

Oncology • 05 May 2026

CCNE1 Gain Defines a Therapy-Refractory Gastric Cancer Subtype

Oncology • 28 Apr 2026

ClinicalTrialsRelated by Conditionprostate cancer

Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy

Oncology • 08 Apr 2026

ClinicalTrialsRelated by Conditionprostate cancer

A Phase Ib/II Open-Label Study Of AMO959 With 177Lu-PSMA-617 In Combination With An ARPI In PSMA

Oncology • 01 Apr 2026

Prostate MRI Beyond Diagnosis: Prognostic Value After Radical Prostatectomy

Oncology • 02 Apr 2026

Prostate MRI Beyond Diagnosis

Oncology • 02 Apr 2026

Feed Metadata

Source

British Journal of Cancer